Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Montazeri, Ali ^a,b  

^a Iranian Institute for Health Sciences Research   (Iran)

^b Iranian Center for Breast Cancer   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BODY IMAGE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL DECISION MAKING; DEPRESSION; DISEASE FREE SURVIVAL; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; FATIGUE; HUMAN; LIMB DISEASE; MASTECTOMY; MENOPAUSAL SYNDROME; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE RESEARCH; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; SEXUALITY; BREAST TUMOR; FEMALE; HEALTH; PUBLICATION;

BREAST NEOPLASMS; FEMALE; HEALTH; HUMANS; PUBLICATIONS; QUALITY OF LIFE;

EID: 53049107462     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-32     Document Type: Review

References (292)

1. Measuring quality of life in oncology: is it worthwhile? Part I. Meaning, purposes, and controversies. A Montazeri CR Gillis J McEwen, Eur J Cancer Care 1996 5 159 167 10.1111/j.1365-2354.1996.tb00228.x
2. Measuring quality of life in oncology: is it worthwhile? Part II. Experiences from the treatment of cancer. A Montazeri CR Gillis J McEwen, Eur J Cancer Care 1996 5 168 175 10.1111/j.1365-2354.1996.tb00229.x
3. How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. A Montazeri R Milroy D Hole J McEwen CR Gillis, Quality of Life Research 2003 12 157 166 10.1023/A:1022232624891 12639062
4. Quality of life in patients with lung cancer: as an important prognostic factor. A Montazeri R Milroy D Hole J McEwen CR Gillis, Lung Cancer 2001 31 233 240 10.1016/S0169-5002(00)00179-3 11165402
5. World Cancer Report. BW Stewart P Paul Kleihues, Lyon, France, International Agency Research on Cancer 2003
6. Descriptive review of the literature on breast cancer outcomes: 1990 through 2000. J Mandelblatt C Armetta KR Yabroff W Liang W Lawreence, J Natl Cancer Inst Monographs 2004 33 8 44 10.1093/jncimonographs/lgh003 15504918
7. Quality of life issues in patients with disseminated breast cancer. MD McEvoy R McCorkle, Cancer 1990 66 1416 1421 10.1002/1097-0142(19900915)66: 14+<1416::AID-CNCR2820661418>3.0.CO;2-D 2205372
8. The impact of breast conserving treatment and mastectomy on the quality of life of early stage breast cancer patients: a review. GM Kiebert JC de Haes CJ van de Velde, J Clin Oncol 1991 9 1059 1070 2033420
9. Assessment of quality of life and benefits from adjuvant therapies in breast cancer. NK Aaronson, Recent Results Cancer Res 1993 127 201 210 8502817
10. Tamoxifen: a review of pharmacoeconomic and quality of life consideration for its use as adjuvant therapy in women with breast cancer. HM Bryson GL Plosker, Pharmaeconomics 1993 4 40 66 10.2165/00019053-199304010-00006
11. Quality of life and other psychological issues in breast cancer. ME Stefanek, Curr Opin Oncol 1994 6 583 586 10.1097/00001622-199411000-00009 7827169
12. Breast cancer in older women: quality of life considerations. PA Ganz, Cancer Control 1994 1 4 372 379 10886990
13. Psychometric properties and responsiveness of the EORTC quality of life questionnaire (QLQ-C30) in patients with breast, ovarian, and lung cancer. D Osoba B Zee J Pater D Warr L Kaizer J Latreille, Qual Life Res 1994 3 353 364 10.1007/BF00451727 7841968
14. Quality of life issues in the treatment of metastatic breast cancer. RW Carlson, Oncology (Williston Park) 1998 12 3 Suppl 4 27 31 9556780
15. Psychological concerns and quality of life in breast cancer survivors. B Leedham PA Ganz, Cancer Invest 1999 17 342 348 10370362
16. Quality of life in women with breast cancer-a review of the literature and implications for nursing practice. T Rustoen S Begnum, Cancer Nurs 2000 23 416 421 10.1097/00002820-200012000-00003 11128120
17. Quality of life and breast cancer: relationship to psychological variables. SL Shapiro AM Lopez GE Schwartz R Bootzin AJ Figueredo C Braden SF Kurker, J Clin Psychol 2001 57 501 509 10.1002/jclp.1026 11255204
18. Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. AH Partridge CA Bunnell EP Winer, Breast Dis 2001 14 41 50 15687635
19. Strategies for improving quality of life in older patients with metastatic breast cancer. JE Kurtz P Dufour, Drugs Aging 2002 19 605 622 10.2165/00002512-200219080-00006 12207554
20. The impact of hormonal treatments on quality of life of patients with metastatic breast cancer. J Costantino, Clinical Ther 2002 24 Suppl C C26 C42 10.1016/S0149-2918(02)85159-1
21. Evolution of breast cancer treatment: current options and quality-of-life consideration. LJ Fallowfield, Eur J Oncol Nurs 2004 8 Suppl 2 S75 82 10.1016/j.ejon.2004.09.005 15590318
22. Enhancing the quality of life of survivors of breast cancer. A Sammarco, Ann Long Term Care 2004 12 40 45
23. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. MT Knobf, Oncologist 2006 11 96 110 10.1634/theoncologist.11-2-96 16476831
24. Side effects of chemotherapy and quality of life in overian and breast cancer patients. AE Kayl CA Meyers, Current Opinion in Obstetric & Gynecology 2006 18 24 28 10.1097/01.gco.0000192996.20040.24
25. Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with metastatic bone disease: a review. IJ Diel, Support Care Cancer 2007 15 1243 1249 10.1007/s00520-007-0244-9 17393190
26. Improving quality of life after breast cancer: prevention of other diseases. S Rozenberg C Antoine B Carly A Pastijn F Liebens, Menopause Int 2007 13 71 74 10.1258/175404507780796398 17540137
27. Quality of life after breast conservation or mastectomy: a systematic review. L Irwig A Bennetts, Aust N Z J Surg 1997 67 750 754 10.1111/j.1445-2197. 1997.tb04573.x 9396988
28. Quality of life in patients undergoing systematic therapy for advanced breast cancer. A Bottomley P Therasse, Lancet Oncol 2002 3 620 628 10.1016/S1470-2045(02)00876-8 12372724
29. Systematic overview of quality of life studies for breast cancer. K Shimozuma T Okamoto N Katsumata M Koike K Tanaka S Osumi M Saito N Shikama T Watanabe M Mitsumori C Yamauchi A Hisashige, Breast Cancer 2002 9 196 202 12185329
30. Health-related quality-of-life measurement in randomized clinical trials in breast cancer. Taking stock. PJ Goodwin JT Black LJ Bordeleau PA Ganz, J Natl Cancer Inst 2003 95 263 281 12591983
31. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. JS Rietman PU Dijkstra HJ Hoekstra WH Eisma BG Szabo JW Groothoff JH Geertzen, Eur J Surg Oncol 2003 29 229 238 10.1053/ejso.2002.1403 12657232
32. Quality of life concerns in patients with breast cancer: evidence for disparity of outcomes and experiences in pain management and palliative care among African-American women. R Payne E Medina JW Hampton, Cancer 2003 97 Suppl 1 311 317 10.1002/cncr.11017
33. Quality of life in randomized trials of cytoxic or hormonal treatment of advanced breast cancer. Is there added value? R Fossati C Confalonieri P Mosconi V Pistotti G Apolone, Breast Cancer Res Treat 2004 87 233 243 10.1007/s10549-004-8694-y 15528966
34. Quality of life among long-term breast cancer survivors: a systematic review. F Mols AJ Vingerthoets JW Coebergh LV van de Poll-Franse, Eur J Cancer 2005 41 2613 2619 10.1016/j.ejca.2005.05.017 16226458
35. Quality of life and adjuvant systemic therapy for breast cancer. PS Grimison M Stockler, Expert Rev Anticancer Ther 2007 7 1123 1134 10.1586/14737140.7.8.1123 18028021
36. Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates, duration and quality of life. FD Moore SB van de Vanter CM Boyden J Lokich RE Wilson, Surgery 1974 76 376 390 4136510
37. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. TJ Priestman M Baum, Lancet 1976 1 899 900 10.1016/S0140-6736(76)92112-7 58161
38. Quality of life in stage II breast cancer: an instrument for clinical trials. MN Levine GH Guyatt M Gent S De Pauw MD Goodyear WM Hryniuk A Arnold B Findlay JR Skillings VH Bramwell, J Clin Oncol 1988 6 1798 1810 3058874
39. Assessment of health related quality of life: factor scales for patients with breast cancer. A Ciampi G Lockwood HJ Sutherland HA Llewellyn-Thomas, J Psychsocial Oncol 1988 6 1 19 10.1300/J077v06n01_01
40. Two simple indexes used to evaluate the impact of therapy on the quality of life of patients receiving primary chemotherapy for operable breast cancer. M Tamburini C Brambilla L Ferrari T Bombino L Gangeri S Rosso, Ann Oncol 1991 2 417 422 1768628
41. Health-related quality of life as a treatment endpoint in metastatic breast cancer. D Osoba, Can J Oncol 1995 5 Suppl 1 47 53 8853525
42. Measurement of quality of life in women with breast cancer. Development of a life satisfaction questionnaire (LSQ-32) and a comparison with the EORTC-C30. M Carlsson E Hamrin, Qual Life Res 1996 5 265 274 10.1007/BF00434748 8998495
43. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. MAG Sprangers M Groenvold JI Arraras J Franklin A te Velde M Muller L Franzini A Williams HC de Haes P Hopwood A Cull NK Aaronson, J Clin Oncol 1996 14 2756 2768 8874337
44. Reliability and validity of the Functional Assessment of Cancer Therapy Breast Quality of Life instrument. MJ Brady DF Cella F Mo AE Bonomi DS Tulsky SR Lloyd S Deasy M Cobleigh G Shiomoto, J Clin Oncol 1997 15 974 986 9060536
45. Quality of life assessment in a cross cultural context: use of the Rotterdam Symptom Checklist in a multinational randomized trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. JC de Haes M Olschewski, Ann Oncol 1998 9 745 750 10.1023/A:1008282806910 9739441
46. Validation of the European Organization for Research and Treatment of Cancer Quality of Life questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. SA McLachlan GM Devins PJ Goodwin, Eur J Cancer 1998 34 510 517 10.1016/S0959-8049(97)10076-4 9713301
47. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. LJ Followfield SK Leaity A Howell S Benson D Cella, Breast Cancer Res Treat 1999 55 189 199 10481946
48. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. A Montazeri I Harirchi M Vahdani F Khaleghi S Jarvandi M Ebrahimi M Haji-Mahmoodi, Qual Life Res 2000 9 177 184 10.1023/A:1008918310251 10983481
49. Evaluation of the Bulgarian version of the European Organization for Research and Treatment of Cancer quality of life questionnaire C30 (version 2) and breast cancer module (BR23) on the psychometric properties of breast cancer patients under adjuvant chemotherapy. Prognostic value of estrogen and progesterone receptors to quality of life. Z Mihailova N Butorin R Antonov N Toporov V Popova, J Balkan Union of Oncol 2001 6 415 424
50. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. S Coster K Poole LJ Fallowfield, Breast Cancer Res Treat 2001 68 273 282 10.1023/A:1012278023233 11727963
51. The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. JS Carpenter, J Pain Symptom Manag 2001 22 979 989 10.1016/S0885-3924(01)00353-0
52. Quality of life in breast cancer patients: validation of FACT-B Malayalam version. M Pandey BC Thomas K Ramdas S Eremenco K Nair, Qual Life Res 2002 11 87 90 10.1023/A:1015083713014 12018741
53. Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. WC Chie KJ Chang CS Huang WH Kuo, Psycho-Oncol 2003 12 729 735 10.1002/pon.727
54. Validation of the functional assessment of cancer therapy-general (FACT-G) scale for measuring the health-related quality of life in Korean women with breast cancer. EH Lee M Chun S Kang HJ Lee, Jap J Clin Oncol 2004 34 393 399 10.1093/jjco/hyh070
55. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer Speicifc Quality of Life Questionnaire (EORTC QLQ-BR23). YH Yun SH Bae IO Kang KH Shin R Lee SI Kwon YS Park ES Lee, Support Care Cancer 2004 12 441 445 10.1007/s00520-004-0632-3 15088137
56. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer. V Parmar RA Badwe R Hawaldar S Rayabhattanavar A Varghese R Sharma I Mittra, Natl Med J India 2005 18 172 177 16252544
57. Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long term cancer survivors in a sample of breast cancer survivors. NE Avis KL Foley, Health Qual Life Outcomes 2006 4 92 17140438 10.1186/1477-7525-4-92
58. Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. C Wan D Zhang Z Yang X Tu W Tang C Feng H Wang X Tang, Breast Cancer Res Treat 2007 106 413 418 10.1007/s10549-007-9511-1 17377841
59. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. C Wan X Tang XM Tu C Feng S Messing Q Meng X Zhang, Breast Cancer Res Treat 2007 105 187 193 10.1007/s10549-006-9443-1 17221159
60. Measurement of quality of life in advanced breast cancer. M Baum SR Ebbs LJ Fallowfield SC Fraser, Acta Oncol 1990 29 391 395 10.3109/02841869009090020 2194541
61. Ratings of the importance of quality of life variables: therapeutic implications. HJ Sutherland GA Lockwood NF Boyd, J Clin Epidemiol 1990 43 661 666 10.1016/0895-4356(90)90036-O 2370573
62. Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group). RD Gelber A Goldhirsch C Hunry J Bernhard RJ Simes, J Natl Cancer Inst Monogr 1992 11 127 135 1385719
63. Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. A Ganz JJ Lee MS Sim ML Polinsky CA Schag, J Clin Epidemiol 1992 45 473 485 10.1016/0895-4356(92)90096-6 1588353
64. Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group. RD Gelber A Goldhirsch BF Cole, Control Clin Trials 1993 14 485 499 10.1016/0197-2456(93)90029-D 8119064
65. Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group Breast Cancer Clinical Trial. KA Hayden CM Moinpour B Metch P Feigl RM O'Bryan S Green CK Osborne, Oncol Nurs Forum 1993 20 1415 1419 8265446
66. Quality of life measurement in breast cancer. LJ Fallowfield, J R Soc Med 1993 86 1 10 12 8423565
67. Framing and labeling effects in health descriptions: quality adjusted life years for treatment of breast cancer. K Gerard M Dobson J Hall, J Clin Epidemiol 1993 46 77 84 10.1016/0895-4356(93)90011-O 8433117
68. Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effects on patient self-estimation. The International Breast Cancer Study Group. C Hurny J Bernhard A Coates M Castiglione HF Peterson RD Gelber CM Rudenstam A Goldhirsch HJ Senn, Ann Oncol 1994 5 65 74 8172795
69. Assessment of quality of life in breast cancer. LJ Fallowfield, Acta Oncol 1995 34 689 694 10.3109/02841869509094050 7546841
70. Measurement and practical aspects of quality of life in breast cancer. PS Hietanen, Acta Oncol 1996 35 39 42 10.3109/02841869609098477 8619938
71. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. J Bernhard C Hurny AS Coates HF Peterson M Castiglione-Gertsch R Gelber A Goldhirsch HJ Senn CM Rudenstam, Ann Oncol 1997 8 825 835 10.1023/A: 1008269715091 9358933
72. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG). J Bernhard C Hurny AS Coates HF Peterson M Castiglione-Gertsch RD Gelber E Galligioni G Marini B Thurlimann JF Forbes A Goldhirsch HJ Senn CM Rudenstam, Br J Cancer 1998 78 686 693 9744512
73. Quality of life of assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data. J Bernhard HF Peterson AS Coates H Gusset M Isley R Hinkle RD Gelber M Castiglione-Gertsch C Hurny, Stat Med 1998 17 587 601 10.1002/(SICI)1097- 0258(19980315/15)17:5/7<587::AID-SIM806>3.0.CO;2-# 9549808
74. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. PA Ganz JH Rowland K Desmond BE Meyerowitz GE Wyatt, J Clin Oncol 1998 16 501 514 9469334
75. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data. A Coates V Gebski, Stat Med 1998 17 5330540 10.1002/(SICI)1097-0258(19980315/15)17:5/7<533::AID-SIM800>3.0. CO;2-Y
76. Response shift in quality of life measurement in early-stage breast cancer patients undergoing radiotherapy. SJT Jansen AM Stiggelbout MA Nooij EM Noordijk J Kievit, Qual Life Res 2000 9 603 615 10.1023/A:1008928617014 11236851
77. Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study. D Curran N Aaronson B Standaert G Molenberghs P Therasse A Ramirez M Koopmanschap H Eder M Piccart, Eur J Cancer 2000 36 834 844 10.1016/S0959-8049(00)00056-3 10785587
78. A longitudinal study of health related quality of life and utility measures in patient with advanced breast cancer. DJ Perez SM Williams EA Christensen RO McGee AV Camplbell, Qual Life Res 2001 10 578 593 10.1023/A:1013193007095
79. Quality of life in breast cancer patients: a cluster analytic approach. GC Nagel S Schmidt BM Strauss D Katenkamp, Breast Cancer Res Treat 2001 68 75 87 10.1023/A:1017975609835 11678311
80. Survival, quality of life and breast cancer. P Mosconi M Colozza MD Laurentiis SD Placido M Maltoni, Ann Oncol 2001 12 Suppl 3 S15 S19 10.1023/A:1013082612737 11804378
81. Quality of life in breast cancer: measurement issues in breast cancer clinical trials. F Efficace A Bottomely GS Collines, Expert Rev Pharmaeconomic Outcomes Res 2002 2 57 65 10.1586/14737167.2.1.57
82. Comparing of 2 quality of life questionnaires in women treated for breast cancer: the RAND 36-Item Health Survey and the Functional Living Index-Cancer. RW Wilson LM Hutson D Vanstry, Physical Therapy 2005 85 851 860 16117596
83. Quality of life among long-term survivors of breast cancer: different types of antecedents predict different class of outcomes. CS Carver RG Smith VM Petronis MH Antoni, Psycho-Oncol 2006 15 749 758 10.1002/pon.1006
84. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. S Perry TL Kowalski CH Chang, Health and Quality of Life Outcomes 2007 5 24 10.1186/1477-7525-5-24
85. Quality of life after breast surgery. JC de Haes MA van Oostrom K Welvaart, J Surg Oncol 1985 28 123 125 10.1002/jso.2930280211 3881629
86. The effect of radical and conserving surgery on the quality of life of early breast cancer patients. JC de Haes MA van Oostrom K Welvaart, Eur J Surg Oncol 1986 12 337 342 3780987
87. Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery. PA Ganz CA Schag JJ Lee ML Polinsy S Tan, Cancer 1992 69 1729 1738 10.1002/1097- 0142(19920401)69:7<1729::AID-CNCR2820690714>3.0.CO;2-D 1551058
88. Analysis of factors associated with quality of life in breast cancer patients after surgery. K Shimozuma H Sonoo K Ichihara J Kurebayashi K Miyake K Yoshikawa K Ota, Breast Cancer 1994 1 123 129 11091520
89. Influencing of age and of different operative methods on the quality of life in patients with breast cancer. M Neises MS Sir HJ Strittmatter, Onkologie 1994 17 410 419
90. Quality of life in the elderly women with breast cancer treated with tamoxifen and surgery or tamoxifen alone. L Fallowfield, J Women's Health 1994 3 17 20
91. The impact of breast conserving treatment and mastectomy on the quality of life in early-stage breast cancer patients. K Shimozuma H Sonoo K Ichihara K Miyake J Kurebayashi K Ota T Kiyono, Breast Cancer 1995 2 35 43 11091530
92. Quality of life among mastectomy patients using external breast prostheses. S Hart BE Meyerowitz G Apolone P Mosconi A Liberati, Tumori 1997 83 581 586 9226025
93. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. M Dorval E Maunsell L Deschenes J Brisson B Masse, J Clin Oncol 1998 16 487 494 9469332
94. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast conserving procedures: results of EORTC trial 10801. D Curran JP van Dongen NK Aaronson G Kiebert IS Fentiman F Mignolet H Bartelink, Eur J Cancer 1998 34 307 314 10.1016/S0959-8049(97)00312-2 9640214
95. Subtle differences in quality of life after breast cancer surgery. IL Wapnir RP Cody RS Greco, Ann Surg Oncol 1999 6 359 366 10.1007/s10434-999-0359-y 10379856
96. Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. K Shimozuma PA Ganz L Petersen K Hirji, Breast Cancer Res Treat 1999 56 45 57 10.1023/A:1006214830854 10517342
97. Surgical options for early-stage breast cancer: factors associated with patient choice and postoperative quality of life. A Pusic TA Thompson CL Kerrigan R Sargeant S Slezak BW Chang KJ Kelzisouer PN Manson, Plast Reconstr Surg 1999 104 1325 1333 10.1097/00006534-199910000-00013 10513913
98. Quality of life in patients with ductal carcionoma in situ of the breast treated with conservative surgery and postoperative irradiation. M Amichetti O Caffo M Arcicasa M Roncadin O Lora A Rigon G Zini L Armaroli F Coghetto P Zorat S Neri N Teodorani, Breast Cancer Res Treat 1999 54 109 115 10.1023/A: 1006125602353 10424401
99. Quality of life three months and one year after first treatment for early stage breast cancer: influence of treatment and patient characteristics. MT King P Kenny A Shiell J Hall J Boyages, Qual Life Res 2000 9 789 800 10.1023/A:1008936830764 11297021
100. Early stage breast cancer, costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy. P Kenny MT King A Sheill J Seymour J Hall A Langlsnds J Boyages, Breast 2000 9 37 44 10.1054/brst.1999.0111 14731583
101. Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. MJ Nissen KK Swenson LJ Ritz JB Farrell ML Sladek RM Lally, Cancer 2001 91 1238 1246 10.1002/1097-0142(20010401)91:7<1238::AID- CNCR1124>3.0.CO;2-X 11283922
102. Quality of life influenced by primary surgical treatment for stage I-III breast cancer-long term follow-up of a matched-pair analysis. W Janni D Rjosk T Dimpfl K Haertl B Strobl F Hepp A Hanke F Bergauer H Sommer, Ann Surg Oncol 2001 8 542 548 11456055
103. Breast reconstruction in the elderly: preserving excellent quality of life. JA Girotto J Schreiber MY Nahabedian, Ann Plast Surg 2003 50 572 578 10.1097/01.SAP.0000069064.68579.19 12783001
104. Better cosmetic results and comparable quality of life skin-sparing mastectomy and immediate autologous breast reconstruction compared to breast conservative treatment. VF Cocquyt PN Blondeel HT Depypere KA van de Sijpe KK Daems SJ Monstrey SJ van Belle, Br J Plast Surg 2003 56 462 470 10.1016/S0007-1226(03)00198-X 12890459
105. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. J Engel J Kerr A Schlesinger-Raab H Sauer D Halzel, Breast J 2004 10 223 231 10.1111/j.1075-122X.2004.21323.x 15125749
106. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. PA Ganz L Kwan AL Stanton JL Krupnick JH Rowland BE Meyerowitz JE Bower TR Belin, J Natl Cancer Inst 2004 96 376 387 14996859
107. Quality of life after sentinel lymph node biopsy in early breast cancer. G Dubernard L Sideris S Delaloge H Marsiglia F Rochard JP Travagli MC Mathieu J Lumbroso M Spielmann JR Garbay R Rouzier, Eur J Surgical Oncol 2004 30 728 734 10.1016/j.ejso.2004.05.006
108. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. EE Elder Y Brandberg T Bjorklund R Rylander J Lagergren G Jurell M Wickman K Sandelin, Breast 2005 14 201 208 10.1016/j.breast.2004.10.008 15927829
109. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. E Barranger G Dubernard J Fleurence M Antoine E Darai S Uzan, J Surg Oncol 2005 92 17 22 10.1002/jso.20343 16180226
110. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. A Fleissig LJ Fallowfield CI Langridge L Johnson RG Newcombe JM Dixon M Kissin RE Mansel, Breast Cancer Res Treat 2006 95 279 293 10.1007/s10549-005-9025-7 16163445
111. Early effect of surgery on quality of life in women with operable breast cancer. M Pandey BC Thomas K Ramdas K Ratheesan, Jap J Clin Oncol 2006 36 468 472 10.1093/jjco/hyl065
112. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. JS Rietman JH Geertzen HJ Hoekstra P Baas WV Dolsma J de Vries JW Groothoff WH Eisma PU Dijkstra, Eur J Surg Oncol 2006 32 148 152 10.1016/j.ejso.2005.11.008 16387467
113. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. PA Parker A Youssef S Walker K Basen-Engquist L Cohen ER Gritz QX Wei GL Robb, Ann Surg Oncol 2007 14 3078 3089 10.1245/s10434-007-9413-9 17574501
114. Adjuvant chemotherapy for breast cancer: side effects and quality of life. BV Palmer GA Walsh JA McKinna WP Greening, Br Med J 1980 281 1594 1597 7004560
115. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. A Coates V Gebski JF Bishop PN Jeal RL Woods R Snyder MH Tattersall M Byrne V Harvey G Gill, N Engl J Med 1987 317 1490 1495 3683485
116. Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. GM Kiebert J Hanneke CJ de Haes J Kievit CJ van de Velde, Eur J Cancer 1990 26 1038 1042 2148877
117. Quality of life adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group. RD Gelber A Goldhirsch F Cavalli, Ann Intern Med 1991 114 621 628 2003707
118. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer. G Berglund C Bolund T Fornander LE Rutqvist PO Sjoden, Eur J Cancer 1991 27 1075 1081 1683557
119. Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. MA Richards P Hopwood AJ Ramirez CJ Twelves J Ferguson WM Gregory R Swindell W Scrivener J Miller A Howell, Eur J Cancer 1992 28 1023 1028 10.1016/0959-8049(92)90447-A
120. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. C Hurny J Bernhard RD Gelber, Eur J Cancer 1992 28 118 124 10.1016/0959-8049(92)90399-M 1567662
121. The impact of chemotherapy on the quality of life of breast cancer patients. E Campora C Naso MT Vitullo S Giudici A Camoirano L Repetto R Rosso, J Chemother 1992 4 59 63 1383437
122. Combination or mild single agent chemotherapy for advanced breast cancer: CMF vs. epirubicin measuring quality of life. SCA Fraser HJ Dobbs SR Ebbes LJ Fallowfield T Bates M Baum, Br J Cancer 1993 67 402 406 8431375
123. Iododoxorubicin in advanced breast cancer-A phase II evaluation of clinical activity, pharmachology and quality of life. CJ Twelves NA Dobbs MA Lawrence AJ Ramirez M Summerhayes MA Richards KE Towlson RD Rubens, Br J Cancer 1994 69 726 731 8142261
124. Quality of life analysis from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer. LA Bertsch G Donaldson, Semin Oncol 1995 22 Suppl 5 45 54
125. Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life. SM Swain J Rowland K Weinfurt C Berg ME Lippman L Walton E Egan D King I Spertus SF Honig, J Clin Oncol 1996 14 1565 1572 8622073
126. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. RP McQuellon B Craven GB Russell S Hoffman JM Cruz JJ Perry DD Hurd, Bone Marrow Transplant 1996 18 579 584 8879621
127. Health-related quality of life in women with breast cancer undergoing atologous stem-cell transplantation. J Larsen A Gradulf G Nordstrom B Bjorkstrand P Ljungman, Cancer Nurs 1996 19 368 375 10.1097/00002820-199610000- 00006 8885485
128. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. C Hurny J Bernhard AS Coates M Castiglione-Gertsch HF Peterson RD Gelber JF Forbes CM Rudenstam E Simoncini D Crivellari A Goldhirsch HJ Senn, Lancet 1996 347 1279 1284 8622502
129. Pilot study reports: Quality of life during high dose chemotherapy for breast cancer. A Griffiths K Beaver, Int J Palliat Nurs 1997 3 138 144
130. Quality of life and preferences for treatment following systematic adjuvant therapy for early-stage breast cancer. C Lindley S Vasa WT Sawyer EP Winer, Clin Oncol 1998 16 1380 1387
131. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. PA Ganz JH Rowland BE Meyerowitz KA Desmond, Recent Results Cancer Res 1998 152 396 411 9928575
132. Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK). J Bernhard M Castiglione-Gertsch SFH Schmitz M Castiglione-Gertsch F Cavalli R Morant MF fey H Bonnefoi A Goldhirsch C Hurny, Eur J Cancer 1999 35 913 920 10.1016/S0959-8049(99)00028-3 10533471
133. Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG). DL Fairclough JH Fetting D Cella W Wonson CM Moinpour, Qual Life Res 1999 8 723 731 10.1023/A:1008806828316 10855346
134. Health-related quality of life in women with metastatic breast cancer treated with trastuzumab (Herceptin). D Osoba M Burchmore, Semin Oncol 1999 26 4 Suppl 12 84 88 10482198
135. Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost. SA McLachlan M Pintillie IF Tannock, Breast Cancer Res Treat 1999 54 213 223 10.1023/A:1006123721205 10445420
136. High-dose sequential chemotherapy with recombination granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? G Macquart-Moulin P Viens T Palangie ML Bouscary T Delozier H Roche M Janvier M Fabbro JP Moatti, J Clin Oncol 2000 18 754 764 10673516
137. Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer. A Riccardi C Tinelli S Brugnatelli P Pugliese V Giardina M Giordano M Danova A Richetti S Fava E Rinaldi V Fregoni G Trotti A Poli, Int J Oncol 2000 16 769 776 10717247
138. Randomized trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist. JA Kramer D Curran M Piccart JC de Haes PF Bruning JG Klijn M Bontenbal C van Pottelsberghe M Groenvold R Paridaens, Eur J Cancer 2000 36 1488 1497 10.1016/S0959-8049(00)00134-9 10930796
139. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in firs-line chemotherapy in advanced breast cancer. JA Kramer D Curran M Piccart JC de Haes PF Bruning JG Klijn I van Hoorebeeck R Paridaens, Eur J Cancer 2000 36 1498 1506 10.1016/S0959-8049(00)00144-1 10930797
140. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy. F Joly M Espie M Marty JF Heron M Henry-Amar, Br J Cancer 2000 83 577 582 10.1054/bjoc.2000.1337 10944595
141. Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicenter randomized phase III trial by the Scandinavian Breast Group. L Hakamies-Blomqvist ML Luoma J Sjostrom A Pluzanska M Sjodin H Mouridsen B Ostenstad I Mjaaland S Ottosson-Lonn J Bergh P Malmstrom C Blomqvist, Eur J Cancer 2000 36 1411 1417 10.1016/S0959-8049(00)00126-X 10899655
142. Quality of life after adjuvant chemotherapy for breast cancer. JA Broeckel PB Jacobsen L Balducci J Horton GH Lyman, Breast Cancer Res Treat 2000 62 141 150 10.1023/A:1006401914682 11016752
143. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. LE Carlson T Koski S Gluck, Bone Marrow Transpl 2001 27 989 998 10.1038/sj.bmt.1703002
144. Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer. D Osoba DJ Slamon M Burchmore M Murphy, J Clin Oncol 2002 20 3106 3113 10.1200/JCO.2002.03.090 12118024
145. Prospective exploratory analysis of the association between tumor response, quality of life, and expenditure among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. S Modi KS Panageas ET Duck A Bach N Weinstock J Dougherty L Cramer C Hudis L Norton A Seidman, J Clin Oncol 2002 20 3665 3673 10.1200/JCO.2002.08.057 12202668
146. Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. E Heidemann H Stoeger R Souchon WD Hirschmann H Bodenstein C Oberhoff JT Fischer M Schulze M Clemens R Andreesen M Mahlke M Konig A Scharl K Fehnle M Kaufmann, Ann Oncol 2002 13 1717 1729 10.1093/annonc/mdf306 12419743
147. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles. D Genre C Protiere G Macquart-Moulin G Gravis J Camerlo C Alzieu D Maraninchi JP Moatite P Viens, Support Care Cancer 2002 10 222 230 10.1007/s00520-001-0322-3 11904787
148. Quality of life in goserelin-treated versus cyclophosphamide plus methotrexate plus fluorouracil-treated premenopausal and perimenopausal patients with node-positive early breast cancer: the Zoladex Early Breast Cancer research Association Trialists Group. H de Haes M Olschewski M Kaufmann M Schumacher W Jonat W Sauerbrei, J Clin Oncol 2003 21 4510 4516 10.1200/JCO.2003.11.064 14610048
149. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. Y Brandberg H Michelson B Nilsson C Bolund B Erikstein P Hietanen S Kaasa J Nilsson T Wiklund N Wilking J Bergh, J Clin Oncol 2003 21 3659 3664 10.1200/JCO.2003.07.020 14512398
150. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23. SR Land JA Kopec G Yothers S Anderson R Day G Tang PA Ganz B Fisher N Wolmark, Breast Cancer Res. Treat 2004 86 153 164 10.1023/B:BREA.0000032983.87966.4e 15319567
151. Quality of life of postmenopausal women in the Arimidex, tamoxifen alone or in combination (ATAC) adjuvant breast cancer trial. L Fallowfield D Cella J Cuzick S Francis G Locker A Howll, J Clin Oncol 2004 22 4261 4271 10.1200/JCO.2004.08.029 15514369
152. Randomized controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study. A Bottomely L Biganzoli T Cufer RE Coleman C Coens F Efficace HA Calvert T Gamucci C Twelves P Fargeot M Piccart, J Clin Oncol 2004 22 13 2576 86 15226325 10.1200/JCO.2004.02.037
153. Quantifying trade-off: quality of life and quality-adjusted survival in a randomized trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer. J Bernhard D Zahrieh AS Coates R Gelber M Castiglione-Gertsch E Murray JF Forbes L Perey J Collins R Snyder CM Rudenstam D Crivellari A Veronesi B Thurlimann MF Fey KN Price A Goldhirsch C Hurny, Br J Cancer 2004 91 1893 1901 10.1038/sj.bjc.6602230 15545973
154. Phase II study of 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer: safety, efficacy and quality of life. DK Tong CW Cheng CS Ching WL Ngor LW Chow, Oncology 2005 68 520 525 10.1159/000086996 16037685
155. Significant negative impact of adjuvant chemotherapy on health-related quality of life (HR-QoL) in women with breast cancer treated by conserving surgery and postoperative 3-D radiotherapy. A prospective measurement. RM Galalae J Michel JU Siebmann T Kuchler K Eilf B Kimmig, Strahlenther Onkol, (Strahlentherapie und Onkologie) 2005 181 645 651 10.1007/s00066-005-1403-x
156. Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs. EB Elkin MC Weinstein KM Kuntz CA Bunnell JC Weeks, Breast Cancer Res Treat 2005 93 25 34 10.1007/s10549-005-3380-2 16184455
157. A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. BL Conner-Spady C Cumming JM Nabholtz P Jacobs D Stewart, Bone Marrow Transplantation 2005 36 251 259 10.1038/sj.bmt.1705032 15937502
158. Health-related quality of life in survivors of locally advanced breast cancer: an international randomized controlled phase III trial. A Bottomley P Therasse M Piccart F Efficace C Coens C Gotay M Welnicka-Jaskiewicz L Mauriac J Dyczka T Cufer MR Lichinitser JH Schornagel H Bonnefoi L Shepherd, Lancet Oncol 2005 6 287 294 10.1016/S1470-2045(05)70100-5 15863376
159. Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. TA Ahles AJ Saykin CT Furstenberg B Cole LA Mott L Ttius-Ernstoff K Skalla M Bakitas PM Silberfarb, J Clin Oncol 2005 23 4399 4405 15994149 10.1200/JCO.2005.03.343
160. Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from cancer and group B 9066. J Peppercorn J Herndon II AB Kornblith W Peters T Ahles J Vredenburgh G Schwartz E Shpall DD Hurd J Holland E Winer, Cancer 2005 104 1580 1589 10.1002/cncr.21363 16118805
161. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomized, placebo-controlled, double-blind, multicentre clinical trial. VF Semiglazov VV Stepula A Dudov J Schnitker U Mengs, Anticancer Res 2006 26 1519 1529 16619567
162. Toxicity and health-related quality of life in breast patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. M Martin a Lluch MA Segui A Ruzi M Ramos E adrover A Rodriguez-Lescure R Grosse L Calvo C Fernandez-Chacon M Roset A Anton D Isla PM del Prado L Iglesias J Zaluski A Arcusa JM Lopez-Vega M Munoz JR Mel, Annal Oncol 2006 17 1205 1212 10.1093/annonc/mdl135
163. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. A Hurria E Zuckerman KS Panageas M Fornier G D'Andrea C Dang M Moasser M Robson A Seidman V Currie C Van Poznak M Theodoulou MS Lachs C Hudis, J Am Geri Soc 2006 54 1119 1124 10.1111/j.1532-5415.2006.00789.x
164. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. LJ Fallowfield JM Bliss LS Porter MH Price CF Snowdon SE Jones RC Coobes E Hall, J Clin Oncol 2006 24 910 917 10.1200/JCO.2005.03.3654 16484701
165. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial. M Groenvold PM Fayers MA Petersen HT Mouridsen, Breast Cancer Res Treat 2006 98 275 284 10.1007/s10549-006-9160-9 16541325
166. Quality of life of postmenopausal women in the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. D Cella L Fallowfield P Barker J Cuzick G Locker A Howell, Breast Cancer Res & Treat 2006 100 273 284 10.1007/s10549-006-9260-6 16944295
167. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA 19. J Liu D Tu J Dancey L Reyno KI Pritchard J Pater LK Seymour, Breast Cancer Res Treat 2006 100 263 271 10.1007/s10549-006-9257-1 16823511
168. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study. MV Karamouzis G Ioannidis G Rigatos, Eur J Cancer Care 2007 16 433 438 10.1111/j.1365-2354.2006. 00771.x
169. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardization of Breast Radiotherapy Trial). P Hopwood J Haviland J Mills G Sumo J M Bliss START Trial Management Group, Breast 2007 16 241 251 10.1016/j.breast.2006.11.003 17236771
170. A daily diary for quality of life measurement in advanced breast cancer trials. SCA Fraser AJ Ramirez SR Ebbes LJ Fallowfield HJ Dobbs MA Richards T Bates M Baum, Br J Cancer 1993 67 341 346 8431363
171. Quality of life in phase II trials-A study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel, plus granulocyte colony stimulating factor. AD Seidman R Portenoy TJ Yao J Lepore EK Mont J Kortmansky N Onetto L Ren J Grechko M Beltangady, J Natl Cancer Inst 1995 187 1316 1322 10.1093/jnci/87.17.1316
172. Quality of life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. AS Coates C Hurny HF Peterson J Bernhard M Castinglione-Gertsch D Gelberg A Goldhirsch, J Clin Oncol 2000 18 3768 3774 11078489
173. Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables. PJ Goodwin M Ennis LJ Bordeleau KT Pritchard Me Trudeau J Koo N Hood, J Clin Oncol 2004 22 4184 4192 10.1200/JCO.2004.12.091 15483029
174. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. F Efficace P Therasse MJ Piccart C Coens K van Steen M Welnicka-Jaskiewicz T Cufer J Dyczka M Lichinitser L Shepherd H de Haes MA Srangers A Bottomley, J Clin Oncol 2004 22 3381 3388 10.1200/JCO.2004.02.060 15310784
175. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trial Group. A Coates V Gebski D Signorini P Murray D McNeil M Byne JF Forbes, J Clin Oncol 1992 10 1833 1838 1453197
176. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. ML Luoma L Hakamies-Blomqvist J Sjostrom A Pluzanska S Ottoson H Mouridsen NO Bengtsson J Bergh P Malmstrom V Valvere L Tennvall C Blomqvist, Eur J Cancer 2003 39 1370 1376 10.1016/S0959-8049(02)00775-X 12826039
177. Baseline health-related quality of life data as prognostic factors in a phase III multicenter study of women with metastatic breast cancer. F Efficace L Biganzoli M Piccart C Coens K van Steen T Cufer RE Coleman HA Calvert T Gamucci C Twelves P Fargeot A Bottomley, Eur J Cancer 2004 40 1021 1030 10.1016/j.ejca.2004.01.014 15093577
178. The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. K Shimozuma H Sonoo K Ichihara K Tanaka, Surg Today 2000 30 255 261 10.1007/s005950050055 10752779
179. Mental adjustment to cancer and quality of life in breast cancer patients-An exploratory study. J Ferrero J Brisson L Deschenes, Psycho-Oncol 1994 3 223 232 10.1002/pon.2960030309
180. Breast cancer survivors: psychosocial concerns and quality of life. PA Ganz A coscarelli C Fred B Kahn ML Polinsky L Petersen, Breast Cancer Res Treat 1996 38 183 199 10.1007/BF01806673 8861837
181. Randomized trial of a psychologic distress screening program after breast cancer: effects on quality of life. E Maunsell J Brisson L Deschenes N Frasure-Smith, J Clin Oncol 1996 14 2747 2755 8874336
182. Psychological adjustment and quality of life in women with breast cancer and benign breast problems-a controlled comparison. MA Andrykowski SL Curran JL Studts L Cunningham JS Carpenter PC McGrath DA Sloan DE Kenady, J Clin Epidemiol 1996 49 827 834 10.1016/0895-4356(96)00028-5 8699200
183. The impact of a psychological intervention on quality of life in non-metastatic breast cancer. G Marchioro G Azzarello F Checchin M Perale R Segati E Sampognaro F Rosetti A Franchin GL Pappagallo O Vinate, Eur J Cancer 1996 32 1612 1615 10.1016/0959-8049(96)00134-7
184. Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy. MA Weitzner CA Meyers KK Stuebing AK Saleeba, Support Care Cancer 1997 5 241 248 10.1007/s005200050067 9176972
185. Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. DW Kissane DM Clarke J Ikin S Bloch GC Smith L Vietta DP McKenzie, Med J Australia 1998 169 192 196 9734576
186. Intrusiveness of illness and quality of life in young women with breast cancer. JR Bloom SL Stewart M Johnston P Banks, Psycho-Oncol 1998 7 89 100 10.1002/(SICI)1099-1611(199803/04)7:2<89::AID-PON293>3.3.CO;2-5
187. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. AJ Longman CJ Braden MH Mishel, Oncol Nurs Forum 1999 26 909 915 10382190
188. Exploring the relationship among spiritual well-being, quality of life, and psychological adjustment in women with breast cancer. SP Cotton EG Levine CM Fitzpatrick KH Dold E Targ, Psycho-Oncol 1999 8 429 438 10.1002/(SICI)1099- 1611(199909/10)8:5<429::AID-PON420>3.0.CO;2-P
189. Quality of life and psychological outcome in long-term survivors of breast cancer: a focus on African-American women. K Ashing-Giwa, J Psychosoc Oncol 1999 17 47 62 10.1300/J077v17n03_03
190. Social support, intrusive thoughts, and quality of life in breast cancer survivors. JA Lewis SL Manne KN DuHamel SMJ Vickburg DH Bovjerg V Currie G Winkel WH Redd, J Behav Med 2001 24 231 245 10.1023/A:1010714722844 11436544
191. Post-traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: a preliminary research. M Amir A Ramati, J Anxiety Disord 2002 16 191 206 10.1016/S0887-6185(02)00095-6
192. Breast cancer in older women: quality of life and psychological adjustment in the 15 months after diagnosis. PA Ganz E Guadagnoli MB Landdrum TL Lash W Rakowski RA Silliman, J Clin Oncol 2003 21 4027 4033 10.1200/JCO.2003.08.097 14581426
193. Quality of life in a randomized trial of group psychological support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. L Bordeleau JP Szalai M Ennis M Leszcz M Speca R Sela R Doll HM Chochinov M Navarro A Arnold KI Pritchard A Bezjak HA Liewellyn-Thomas CA Sawka PJ Goodwin, J Clin Oncol 2003 21 1944 1951 10.1200/JCO.2003.04.080 12743147
194. Depression burden, psychological adjustment, and quality of life in women with breast cancer: patterns over time. TA Badger CJ Braden MH Mishel A Longman, Res Nurs Health 2004 27 19 28 10.1002/nur.20002 14745853
195. Anxiety and quality of life of women receive radiation or chemotherapy for breast cancer. AM Schreier SA Williams, Oncol Nurs Forum 2004 31 127 130 10.1188/04.ONF.127-130 14722597
196. Coping strategies and quality of life in women with advanced breast cancer and their family caregivers. T Kershaw L Northouse C kritpracha A Schafenacker D Mood, Psychol Health 2004 19 139 155 10.1080/08870440310001652687
197. Predictor of quality of life in newly diagnosed melanoma and breast cancer patients. US Lehto M Ojanen P Kellokumpu-Lehtinen, Annal Oncol 2005 16 805 816 10.1093/annonc/mdi146
198. Quality of life and affective distress in women seeking immediate versus delayed breast reconstruction after mastectomy for breast cancer. RS Roth JC Lowery J Davis E Wilkins, Plastic & Reconstruction Surgery 2005 116 993 1002 10.1097/01.prs.0000178395.19992.ca
199. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. M Okamura S Yamavaki T Akechi K Taniguchi Y Uchitomi, Jap J Clin Oncol 2005 35 302 309 10.1093/jjco/hyi097
200. Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. DM Golden-Kreutz LM Thornton GS Wells-Di GM Frierson HS Jim KM Carpenter RA Shelby BL Andersen, Health Psychology 2005 24 288 296 15898865 10.1037/0278-6133.24.3.288
201. Ending treatment: the course of emotional adjustment and quality of life among breast cancer survivors immediately following radiation therapy. T Deshields T Tibbs MY Fan L Bayer M Taylor E Fisher, Support Care Cancer 2005 13 1018 1026 10.1007/s00520-005-0801-z 15800768
202. Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or johrei: a short report. T Laid law BM Bennett P Dwivedi A Naito J Gruzellier, Contemp Hypn 2005 22 84 93 10.1002/ch.27
203. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-upstudy compared with the general population. I Schou O Ekeberg L Sandvik MJ Hjermstad CM Ruland, Qual Life Res 2005 14 1813 1823 10.1007/s11136-005-4344-z 16155769
204. Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. B Grabsch DM Clarke A Love DP McKenzie RD Snyder S Bloch G Smith DW Kissane, Palliat Support Care 2006 4 47 56 16889323
205. How stress management improves quality of life after treatment for breast cancer. MH Antoni SC Lechner A Kazi SR Wimberly T Sifre KR Urcuyo K Phillips S Gluck CS Carver, J Consult Clin Psychol 2006 74 6 1143 1152 17154743
206. Uncertainty appraisal coping and quality of life in breast cancer survivors. T Wonghongkul N Dechaprom L Phumivichuvate S Losawatkul, Cancer Nurs 29 250 257 10.1097/00002820-200605000-00014 16783127
207. Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan. JY Yen CH Ko CF Yen MJ Yang CY Wu CH Juan MF Hou, Psychiatry & Clinical Neurosciences 2006 60 147 153 10.1111/j.1440-1819.2006.01479.x
208. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. ES Costanzo SK Lutgendorf ML Mattes S Trehan CB Robinson F Tewfik SL Roman, Br J Cancer 2007 97 1625 1631 10.1038/sj.bjc.6604091 18000503
209. Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor. WS Wong R Fielding, Support Care Cancer 2007 15 1223 1230 10.1007/s00520-006-0190-y 17205280
210. Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. KD Meneses P McNees VW Loerzel X Su Y Zhang LA Hassey, Oncol Nurs Forum 2007 34 1007 1016 10.1188/07.ONF.1007-1016 17878129
211. Psychosocial aspects of breast cancer treatment. D Spiegel, Semin Oncol 1997 24 1 Suppl 1 S1 36-S1-47 9045314
212. Psychological issues confronting young women with breast cancer. DH Baucom LS Porter JS Kiby TM Gremore FJ Keefe, Breast Dis 2006 23 103 113 16823173
213. Depression, quality of life and breast cancer: a review of the literature. M Reich A Lesur C Perdrizet-Chevallier, Breast Cancer Res Treat 2008 110 9 17 10.1007/s10549-007-9706-5 17674188
214. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. M Groenvold MA Petersen E Idler JB Bjorner PM fayers HT Mouridsen, Breast Cancer Res Treat 2007 105 209 219 10.1007/s10549-006-9447-x 17203386
215. Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life. E Kenne Sarenmalm J Ohlén T Jonsson F Gaston-Johansson, J Pain Symptom Manage 2007 34 24 39 10.1016/j.jpainsymman. 2006.10.017 17544244
216. Mind matters. Coping and cancer progression. D Spiegel, J Psychosom Res 2001 50 287 290 10.1016/S0022-3999(00)00200-2 11399287
217. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. AT van Holten-Verzantvoort AH Zwinderman NK Aaronson J Hermans B van Emmerik FS van Dam B van den Bos OL Bijvoet FJ Cleton, Eur J Cancer 1991 27 544 549 1675865
218. A retrospective investigation of the relationship between aerobic exercise and quality of life in women with breast cancer. S Young-McCaughan DL Sexton, Oncol Nurs Forum 1991 18 751 757 2067964
219. Ondansetron compared with Metoclopramide in the control of emesis: quality of life during repeated chemotherapy for breast cancer. M Soukop B McQuade E Hunter A Stewart S Kaye J Cassidy D Kerr S Khanna J Smyth R Coleman, Oncology 1992 49 295 304 1387929
220. Effect of megestrol acetate on quality of life in dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. AB Kornblith DR Hollis E Zuckerman AP Lyss GP Canello MR Cooper JE Herndon CA Phillips J Abrams J Aisner, J Clin Oncol 1993 11 2081 2089 8229122
221. Improved control of emesis and quality of life with Ondansetron in breast cancer. M Clavel M Soukop YL Greenstreet, Oncology 1993 50 180 185 8459989
222. One-on-one peer support and quality of life for breast cancer patients. FD Ashbury C Cameron SL Mercer M Fitch E Nielsen, Patient Educ Couns 1998 35 89 100 10.1016/S0738-3991(98)00035-4 10026552
223. Quality of life and breast cancer survivors: psychological and treatment issues. CO Lee, Cancer Pract 1997 5 309 316 9341354
224. Effects of a nursing intervention on subjective distress, side-effects and quality of life of breast cancer patients receiving curative radiation therapy: a randomized study. Y Wengstrom C Haggmark H Strander C Forsberg, Acta Oncol 1999 38 763 770 10.1080/028418699432923 10522767
225. Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer. J Lachaine C Laurier A Langleben L Vaillant, Crit Rev Oncol Hematol 1999 32 105 112 10.1016/S1040-8428(99)00025-6 10612010
226. Effects of advanced nursing care on quality of life and cost outcomes in women diagnosed with breast cancer. LJ Ritz MJ Nissen KK Swenson JB Farrell PW Sperduto ML Sladek RM Lally LM Schroeder, Oncol Nurs Forum 2000 27 923 932 10920832
227. Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. S Molenaar MAG Sprangers EJT Rutgers EJT Luiten J Mulder MM Boss JJE van Everdingen P Oosterveld HCJM de Haes, J Clin Oncol 2001 19 1676 1687 11250997
228. Perceived social support, uncertainty, and quality of life of younger breast cancer survivors. A Sammarco, Cancer Nurs 2001 24 212 219 10.1097/00002820-200106000-00010 11409065
229. Social networks and health related quality of life in breast cancer survivors: A prospective study. YL Michael LF Berkman GA Colditz MD Holmes I Kawachi, J Psychosomatic Res 2002 52 285 293 10.1016/S0022-3999(01)00270-7
230. Erythropoietin treatment in metastatic breast cancer: effects on Hb, quality of life and need for transfusion. AM Olsson JH Svensson J Sundstrom S Bergstrom T Edekling G Carlsson J Hansen B Sevnsson M Albertsson, Acta Oncol 2002 41 517 524 10.1080/02841860214960 12546524
231. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. JA O'Shaughnessy, Clin Breast Cancer 2002 3 Suppl 3 S116 S120 10.3816/CBC.2002.s. 022 12533272
232. Quality of life pilot intervention for breast cancer patients: use of social cognitive theory. KD Graves CL Carter ES Anderson RA Winett, Palliative Supportive Care 2003 1 121 134 16594274
233. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. KS Courneya JR Mackey GJ Bell LW Jones CJ Field AS Fairey, J Clin Oncol 2003 21 1660 1668 10.1200/JCO.2003.04.093 12721239
234. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Turner S Hayes H Reul-Hirche, J Surg Oncol 2004 86 141 146 10.1002/jso.20065 15170652
235. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. JA Headley KK Ownby LD John, Oncol Nurs Forum 2004 31 977 983 10.1188/04.ONF.977-983 15378098
236. Health-related quality of life among patients with breast cancer receiving zoledronic asid or pamidornate disodium for metastatic bone lesion. KP Weinfurt LD Castel Y Li JW Timbie GA Glendenning KA Schulman, Med Care 2004 42 164 175 10.1097/01.mlr.0000108746.69256.45 14734954
237. Improved quality of life after long-term treatment with bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. IJ Diel JJ Body MR Lichinitser ED Kreuser W Dornoff VA Gorbunova M Budde B Bergstrom, Eur J Cancer 2004 40 1704 1712 10.1016/j.ejca.2004.03.025 15251160
238. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. JJ Body IJ Diel R Bell M Pecherstorfer MR Lichinitser AF Lazarev D Tripathy B Bergstrom, Pain 2004 111 306 312 10.1016/j.pain.2004.07.011 15363874
239. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomized, crossover study of community vs hospital bisphosphonate administration. A Wardley N Davidson P Barrett-Lee A Hong J Mansi D Dodwell R Murphy T Mason D Cameron, Br J Cancer 2005 92 1869 1876 10.1038/sj.bjc.6602551 15870721
240. Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life. HJ Yoo SH Ahn SB Kim WK Kim OS Han, Support Care Cancer 2005 13 826 833 10.1007/s00520-005-0806-7 15856335
241. Social support as a mediator between symptom distress and quality of life in women with breast cancer. J Manning-Walsh, J Obstetric, Gyneocologic Neonatal Nurs 2005 34 482 493 10.1177/0884217505278310
242. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. LG Gordon D Battistutta P Scuffham M Tweeddale B Newman, Breast Cancer Res Treat 2005 93 217 226 10.1007/s10549-005- 5151-5 16136270
243. Influence of exercise activity on quality of life in long term breast cancer survivors. AR Kendall M Mahue-Giangreco CL Carpenter PA Ganz L Bernstein, Qual Life Res 2005 14 361 371 10.1007/s11136-004-1468-5 15892425
244. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Chang F Couture S Young K McWatters CY Lau, J Clin Oncol 2005 23 2597 25605 10.1200/JCO.2004.12.027 15452188
245. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. CA Hudis CL Vogel JR Gralow D Williams, Clin Breast Cancer 2005 6 132 142 10.3816/CBC.2005.n.015 16001991
246. Telephone interpersonal counseling with women with breast cancer: symptom management and quality of life. T Badger C Segrin P Meek AM Lopez E Bonham A Sieger, Oncol Nurs Forum 2005 32 273 279 10.1188/05.ONF.273-279 15759065
247. Full-body exercise training improves fitness and quality of life in survivors of breast cancer. BSB Cheema CA Gaul, J Strenght Condition Res 2006 20 14 21 10.1519/R-17335.1
248. Effects of mutual dyad support on quality of life in women with breast cancer. LB Sutton JA Erlen, Cancer Nurs 2006 29 488 498 10.1097/00002820- 200611000-00010 17135823
249. How do recovery advice and behavioral characteristics influence upper-body function and quality of life among women 6 months after breast cancer diagnosis? T Round SC Hayes B Newman, Support Care Cancer 2006 14 22 29 10.1007/s00520-005-0838-z 16012817
250. The effect of peer counseling on quality of life following diagnosis of breast cancer: an observational study. J Giese-Davis C Bliss-Isberg K Carson P Star J Donaghy MJ Cordova N Stevens L Wittenberg C Batten D Spiegel, Psycho-Oncol 2006 15 1014 1022 10.1002/pon.1037
251. Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life. AB Moadel C Shah J Wylie-Rosett MS Harris SR Patel CB Hall JA Sparano, J Clin Oncol 2007 25 4387 4395 10.1200/JCO.2006.06.6027 17785709
252. Effects of a step-by-step inpatient rehabilitation programme on quality of life in breast cancer patients. A prospective randomized study. U Hartmann R Muche M Reuss-Borst, Onkologie 2007 30 177 182 10.1159/000099989 17396040
253. Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral leymphedema. SJ Kim CH Yi OY Kwon, Lymphology 2007 40 143 151 18062617
254. Fatigue and quality of life following radiotherapy for breast cancer: a comparative study. DM Hann P Jacobson S Martin, J Clin Psychol Med S 1998 5 19 33 10.1023/A:1026249702250
255. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. JS Carpenter MA Andrykowski M Cordova L Cunningham J Studts P McGrath D Kenady D Sloan R Munn, Cancer 1998 82 1682 1691 10.1002/(SICI)1097-0142(19980501)82: 9<1682::AID-CNCR14>3.0.CO;2-0 9576289
256. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. DM Hann N Garovoy B Finkelstein PB Jacobsen LM Azzarello KK Fields, J Pain Symptom Manage 1999 17 313 319 10.1016/S0885-3924(99)00007-X
257. Quality of life of breast cancer patients with lymphedema: high-dose versus standard-dose chemotherapy. V Velanovich W Szymanski, Am J Surg 1999 177 184 187 10.1016/S0002-9610(99)00008-2 10219851
258. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. JE Bower PA Ganz KA Desmond JH Rowland BE Meyetowitz TR Belin, J Clin Oncol 2000 18 743 753 10673515
259. Long term morbidity following axillary dissection in breast cancer patients: clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. T Kuehn W Klauss M Darsow S Regele F Flock C Maiterth R Dahlbender I Wendt R Kreienberg, Breast Cancer Res Treat 2000 64 275 286 10.1023/A:1026564723698 11200778
260. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. KD Stein PB Jacobsen DM Hann H Greenberg G Lyman, J Pain Symptom Manage 2000 19 436 445 10.1016/S0885-3924(00)00142-1 10908824
261. Lymphedema and quality of life in survivors of early-stage breast cancer. SM Beaulac LA McNair TE Scott, Arch Surg 2002 137 1253 1257 10.1001/archsurg.137.11.1253 12413312
262. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. W Kwan J Jackson LM Weir C Dingee G McGregor IA Olivotto, J Clin Oncol 2002 20 4242 4248 10.1200/JCO.2002.09.018 12377968
263. Sleep and quality of life in breast cancer patients. BV Fortner EJ Stepanski SC Wang S Kasprowicz H Durrence, J Pain Symptom Manag 2002 24 471 480 10.1016/S0885-3924(02)00500-6
264. Axilla surgery severely affect quality of life: results of a 5-year prospective study in breast cancer patients. J Engel J Kerr A Schlesinger-Raab H Sauer D Holzel, Breast Cancer Res Treat 2003 79 47 57 10.1023/A:1023330206021 12779081
265. Pain and quality of life after surgery for breast cancer. O Caffo M Amichetti A Ferro A Lucenti F Valduga E Galligioni, Breast Cancer Res Treat 2003 80 39 48 10.1023/A:1024435101619 12889597
266. Impairments, disabilities and health related quality of life after treatment of breast cancer: a follow-up study 2.7 years after surgery. J Rietman P Dijkstra R Debreczeni J Geertzen D Robinson J de Vries, Disabil Rehabil 2004 26 78 84 10.1080/09638280310001629642 14668143
267. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. PN Schults MJ Klein ML Beck C Stava RV Sellin, J Clin Nurs 2005 14 204 211 10.1111/j.1365-2702.2004.01030.x 15669929
268. Quality of life and a symptom cluster associated with breast cancer treatment-related lymph edema. SH Ridner, Support Care Cancer 2005 13 904 911 10.1007/s00520-005-0810-y 15812652
269. Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. DM Conde AM Pinto-Neto C Cabello D Santos-Sa L Costa-Paiva EZ Martinze, Menopause 2005 12 436 443 10.1097/01.GME.0000151655. 10243.48 16037759
270. Effects of chronic widespread pain on the health status and quality of life of women after breast cancer surgery. CS Burckhardt S Carol KD Jones, Health Qual Life Outcomes 2005 3 30 15860132 10.1186/1477-7525-3-30
271. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. PJ Mills B Parker JE Dimsdale GR Sadler S Ancoli-Israel, Biol Psychol 2005 69 85 96 10.1016/j.biopsycho.2004.11.007 15740827
272. Effects of switching from tamoxifen to anastrozole on tamoxifen-related endocrine symptoms and quality of life. C Massacesi E Sabbatini MB Rocchi L Zepponi S Rossini A Pilone L Burattini M Pezzoli, Am J Cancer 2006 5 433 440 10.2165/00024669-200605060-00009
273. Patient reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. SR Land DL Wickerham JP Costantino MW Ritter VG Vogel MK Lee ER Pajon JLIII Wade S Dakhil JB Lockhart N Wolmark PA Ganz, JAMA 2006 295 2742 2751 10.1001/jama.295.23.joc60075 16754728
274. Symptoms, symptom beliefs, and quality of life of older breast cancer survivors: a comparative study. SM Heidrich JJ Egan P Hengudomsub SM Randolph, Oncol Nurs Forum 2006 33 315 22 10.1188/06.ONF.315-322 16518447
275. Menopausal symptoms in women treated for breast cancer; the prevalence and severity of symptoms and their perceived effects on quality of life. P Gupta DW Sturdee SL Pallin K Majumder R Fear T Marshall I Paterson, Climacteric 2006 9 49 58 10.1080/13697130500487224 16428125
276. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms and quality of life. KL Byar AM Berger SL Bakken MA Cetak, Oncol Nurs Forum 2006 33 E18 E26 10.1188/06.ONF.E18-E26 16470230
277. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. V Arndt C Stegmaier H Ziegler H Brenner, Cancer 2006 107 2496 2503 10.1002/cncr.22274 17048250
278. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. A Pyszel K Malyszezak K Pyszel R Andrzejak A Szuba, Lymphology 2006 39 185 192 17319631
279. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. PC Dagnelie MC Pijls-Johannesma P Lambin S Beijer D De Ruysscher GI Kempen, Ann Oncol 2007 18 940 944 10.1093/annonc/mdm057 17363839
280. Symptom experience and quality of life of women following breast cancer treatment. NK Janz M Mujahid LK Chung PM Lantz ST Hawley M Morrow K Schwartz SJ Katz, J Women's Health 2007 16 1348 1361 10.1089/jwh.2006.0255
281. Sexual function as a quality of life issue: the impact of breast cancer treatment. J Knapp, J Gynecol Oncol Nurs 1997 7 37 40
282. Sexuality, body image, and quality of life after high dose or conventional chemotherapy for metastatic breast cancer. K Makar CE Cumming AW Lees M Hundleby J Nabholtz DK Kieren H Jenkins C Wentzel M Handman DC Cumming, Canadian J Human Sexuality 1997 6 1 8
283. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. PA Ganz JH Rowland K Desmond BE Meyerowitz GE Wyatt, J Clin Oncol 1998 16 501 514 9469334
284. The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality: a pilot study. J Marsden M Baum R A'Hern A West L Fallowfield M Whitehead N Sacks, Br J Menopause Sco 2001 7 85 87 10.1258/136218001100321155
285. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. KM Malinovszky A Gould E Foster D Cameron A Humphreys J Crown RC Leonard, Br J Cancer 2006 95 1626 1631 10.1038/sj.bjc.6603454 17160080
286. Sexual quality of life in women with newly diagnosed breast cancer. E Beckjord BE Campas, J Psychosoc Oncol 2007 25 19 36 10.1300/J077v25n02_02 17613483
287. The Satisfaction with Life Domains Scale for Breast Cancer (SLDS-BC). S Spagnola J Zabora K BrintzenhofeSzoc C Hooker G Cohen F Baker, Breast J 2003 9 463 471 10.1046/j.1524-4741.2003.09603.x 14616940
288. Reliability and validity of the Body Image After Breast Cancer Questionnaire. NN Baxter PJ Goodwin RS Mcleod R Dion G Devins C Bombardier, Breast J 2006 12 221 232 10.1111/j.1075-122X.2006.00246.x 16684320
289. Fallowfield's Sexual Activity Questionnaire in women with without and at risk of cancer. L Atkins LJ Fallowfield, Menopause Int 2007 13 103 109 10.1258/175404507781605578 17785035
290. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. D Cella LJ Fallowfield, Breast Cancer Res Treat
291. Quality of life among younger women with breast cancer. NE Avis S Crawford J Manuel, J Clin Oncol 2005 23 3322 3330 10.1200/JCO.2005.05.130 15908646
292. Quality of life in breast cancer: what we have learned and where do we go from here? PA Ganz PJ Goodwin, Outcomes Assessment in Cancer: Measures, Methods, and Applications Cambridge, United Kingdom, Cambridge University Press, Lipscomb J, Gotay CC, Snyder C, 2005 93 125